Zyvestra
Product Images NDC 57520-0398

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Zyvestra (NDC 57520-0398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotheca Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Zyvestra (Mm1)

Zyvestra (Mm1)
This is a drug information sheet containing details about the active ingredients, purpose, warnings, directions, and inactive ingredients of a medication. The medication is aimed to treat symptoms such as vertigo, nausea, headache, and tingling in the ears. The active ingredients are Coceulus Indicus, Ferrum Metallicum, Gelsemium Sempervirens, Phytolacca Decandra, Pulsatla, and Siicea. It is advised to consult a physician before use if pregnant, breastfeeding, or taking other medications, and to stop use and seek medical attention if symptoms worsen, persist for more than 48 hours, or fever develops. The medication is in tablet form and contains lactose, magnesium stearate, and microcrystalline cellulose as inactive ingredients. A helpline number is provided for questions and comments.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.